Please provide your email address to receive an email when new articles are posted on . PET with a novel radiotracer met its primary endpoint for sensitivity and specificity of CAD detection, ...
Bone SPECT is better than FDG PET for detecting breast cancer that has spread (metastasized) to a patient's bones, according to researchers from Shizuoka Cancer Center Hospital in Japan. FDG PET is an ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.
Chengdu Brilliant Pharmaceutical Co. Ltd. and Chengdu Xinke Pharmaceutical Co. Ltd. have disclosed drug conjugates comprising a bone-targeting moiety covalently bound to a radiolabeled-chelating agent ...
Whole cell preparations of MCF-7 breast carcinoma cells are more active than lysed cell preparations in lymphocyte blastogenesis assays (LBAs) of breast cancer patients No significant financial ...
Cornell University and The General Hospital Corp. (Massachusetts General Hospital) have synthesized conjugates comprising a targeting moiety covalently linked to a radiolabeled metal chelator through ...
U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
Reston, VA (October 13, 2025)--A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results